NCT02528500View on ClinicalTrials.gov

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

February 28, 2023

Conditions
Thoracoabdominal Aortic Aneurysm
Interventions
DEVICE

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Non-randomized, multicenter study designed to assess the initial feasibility of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)

Trial Locations (6)

10029

The Mount Sinai Medical Center, New York

15213

UPMC, Pittsburgh

27599

University of North Carolina Chapel Hill, Chapel Hill

55905

Mayo Clinic, Rochester

63110

Washington University School of Medicine, St Louis

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT02528500 - GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms | Biotech Hunter | Biotech Hunter